Zentalis Pharmaceuticals, Inc. (ZNTL)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 71
-0.05
-1.3298%
After Hours
$
+0.05 +1.3477% 3. 76
267.66M Market Cap
- P/E Ratio
- Div Yield
863,023 Volume
-3.66 Eps
$ 3.76
Previous Close 
Want to track ZNTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zentalis Pharmaceuticals, Inc. (ZNTL) Statistics
Valuation metrics
Market Cap 267.66M
Enterprise value 283.42M
Trailing P/E (ttm) -1.54
Forward P/E -
PEG ratio 0.06
Price/Sales (ttm) -
Price/Book (mrq) 1.86
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 695.39K
Average volume (90 days) 1.62M
Price summary
52-Week low 1.21
52-Week high 6.95
Beta -
50-Day moving average 4.66
200-Day moving average 3.56
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.81%
Return on equity -0.88%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.49
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.49
Total debt (mrq) -
Total Debt/Equity (mrq) 0.26
Current ratio (mrq) 4.82%
Book value per share (mrq) 2.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
